Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

7.79
Delayed Data
As of Jul 31
 +0.18 / +2.37%
Today’s Change
3.44
Today|||52-Week Range
8.83
+75.06%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close7.61
Today’s open7.68
Day’s range7.46 - 7.86
Volume830,987
Average volume (3 months)1,168,950
Market cap$1.4B
Dividend yield--
Data as of 4:03pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-63.64%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+71.23%
P/E ratioNM
Price/Sales44.34
Price/Book26.39

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...-0.16-0.17%
ACORAcorda Therapeutics ...+0.13+0.38%
ZSPHZS Pharma Inc+0.91+1.55%
IRWDIronwood Pharmaceuti...-0.02-0.19%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$15.0M
Annual profit (last year)-$54.2M
Net profit margin-360.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts